RecruitingNCT06581861

PREVENT ALL ALS Study

Studying Amyotrophic Lateral Sclerosis (ALS)

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Enrollment: 600 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2029

Study locations (30)

University of Alabama Birmingham, Birmingham, Alabama, United States
Barrow Neurological Institute, Phoenix, Arizona, United States
University of California San Diego, La Jolla, California, United States
University of California Irvine, Orange, California, United States
University of California, San Francisco, San Francisco, California, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Hospital for Special Care, New Britain, Connecticut, United States
Georgetown University, Washington D.C., District of Columbia, United States
Mayo Clinic, Jacksonville, Florida, United States
Saint Alphonsus Regional Medical Center, Boise, Idaho, United States
Northwestern University, Chicago, Illinois, United States
Indiana University, Indianapolis, Indiana, United States
John Hopkins University, Baltimore, Maryland, United States
Nih/Ninds, Bethesda, Maryland, United States
Massachusetts General Brigham, Boston, Massachusetts, United States
+15 more locations on ClinicalTrials.gov

Collaborators

Massachusetts General Hospital · National Institute of Neurological Disorders and Stroke (NINDS) · Foundation for the National Institutes of Health

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06581861 on ClinicalTrials.gov

Other trials for Amyotrophic Lateral Sclerosis (ALS)

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic Lateral Sclerosis (ALS) →

← Back to all trials